Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2019

20.05.2019

Socioeconomic disparities in health-related quality of life among colorectal cancer survivors

verfasst von: Jean A. McDougall, Cindy K. Blair, Charles L. Wiggins, Michael B. Goodwin, Vi K. Chiu, Ashwani Rajput, Anita Y. Kinney

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Improvements in colorectal cancer (CRC) prevention, early detection, and treatment have resulted in substantial gains in survival. However, the health-related quality of life (HRQoL) of CRC survivors often depends on access to supportive care, which differs by survivors’ socioeconomic characteristics. The purpose of this study was to investigate the relationship between socioeconomic characteristics and HRQoL in a diverse group of CRC survivors.

Methods

We conducted a population-based, cross-sectional study to examine the association between socioeconomic factors (household income, health literacy, and insurance status) and HRQoL domains of pain interference, fatigue, physical function, sleep disturbance, anxiety, and depression. PROMIS® Short Forms v.2.0 were used to assess domains of HRQoL. Linear regression modeling was used to estimate the coefficient representing the average HRQoL domain score and its 95% confidence interval (CI).

Results

Three hundred one CRC survivors participated in the survey. Low-income (≤ $30,000) CRC survivors had, on average, a 4.70-point (95% CI 1.10–8.28) higher pain interference score, a 7.02-point (95% CI 3.27–10.77) higher fatigue score, a 5.13-point (95% CI − 8.56 to − 1.71) lower physical function score, and a 4.44-point (95% 1.40–7.49) higher depression score than CRC survivors with an income ≥ $70,000. Survivors with Medicaid insurance reported significantly greater pain interference and worse physical function than privately insured survivors. Survivors with low health literacy reported significantly greater pain interference compared with survivors with high health literacy.

Conclusions

Substantial socioeconomic disparities in HRQoL were observed in this diverse population of CRC survivors.

Implications for Cancer Survivors

Designing supportive care interventions to improve HRQoL among low-income and Medicaid-insured CRC survivors is critical for eliminating disparities in CRC outcomes.
Literatur
3.
Zurück zum Zitat Mols F, Schoormans D, de Hingh I, Oerlemans S, Husson O. Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: prevalence, predictors, and impact on quality of life. Cancer. 2018;124:2621–8. https://doi.org/10.1002/cncr.31369.CrossRefPubMed Mols F, Schoormans D, de Hingh I, Oerlemans S, Husson O. Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: prevalence, predictors, and impact on quality of life. Cancer. 2018;124:2621–8. https://​doi.​org/​10.​1002/​cncr.​31369.CrossRefPubMed
5.
11.
Zurück zum Zitat Young J, Harrison J, Solomon M, Butow P, Dennis R, Robson D, et al. Development and feasibility assessment of telephone-delivered supportive care to improve outcomes for patients with colorectal cancer: pilot study of the CONNECT intervention. Support Care Cancer. 2010;18(4):461–70. https://doi.org/10.1007/s00520-009-0689-0.CrossRefPubMed Young J, Harrison J, Solomon M, Butow P, Dennis R, Robson D, et al. Development and feasibility assessment of telephone-delivered supportive care to improve outcomes for patients with colorectal cancer: pilot study of the CONNECT intervention. Support Care Cancer. 2010;18(4):461–70. https://​doi.​org/​10.​1007/​s00520-009-0689-0.CrossRefPubMed
13.
Zurück zum Zitat Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000;88(6):1294–303.CrossRefPubMed Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000;88(6):1294–303.CrossRefPubMed
19.
Zurück zum Zitat Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.PubMed Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.PubMed
20.
Zurück zum Zitat SEER Program coding and staging manual 2018, (2018). SEER Program coding and staging manual 2018, (2018).
25.
28.
Zurück zum Zitat Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–1, 149. Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–1, 149.
Metadaten
Titel
Socioeconomic disparities in health-related quality of life among colorectal cancer survivors
verfasst von
Jean A. McDougall
Cindy K. Blair
Charles L. Wiggins
Michael B. Goodwin
Vi K. Chiu
Ashwani Rajput
Anita Y. Kinney
Publikationsdatum
20.05.2019
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2019
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-019-00767-9

Weitere Artikel der Ausgabe 3/2019

Journal of Cancer Survivorship 3/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.